Clinical Trial Update: Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (MAINSTREAM) is evaluating whether sacubitril/valsartan can prevent cardiotoxicity from breast cancer therapy; the study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Entresto (sacubitril/valsartan) (sacubitril/valsartan)

Snippet

Sponsor: Silesian Centre for Heart Diseases | Conditions: Breast Cancer, Neoplasm, Breast | Phase 4 | Status: RECRUITING